These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1833566)

  • 1. [Experimental and clinical studies of therapy and physiopathology of cardiac failure].
    Jpn Circ J; 1991; 55 Suppl 2():305-27. PubMed ID: 1833566
    [No Abstract]   [Full Text] [Related]  

  • 2. The heart in congestive failure.
    Katz AM
    Cardioscience; 1990 Mar; 1(1):3-6. PubMed ID: 2151711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Biochemical problems in cardiac hypertrophy and chronic insufficiency].
    Swynghedauw B
    Nouv Presse Med; 1979 Oct; 8(38):3021-4. PubMed ID: 160541
    [No Abstract]   [Full Text] [Related]  

  • 4. Congestive heart failure--pathophysiology and medical treatment.
    Remme WJ
    J Cardiovasc Pharmacol; 1986; 8 Suppl 1():S36-52. PubMed ID: 2422492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Enhanced cardiac contractility after gene therapy].
    Leszek P
    Kardiol Pol; 2003 Dec; 59 Suppl 2():II5-16. PubMed ID: 20527123
    [No Abstract]   [Full Text] [Related]  

  • 6. The effects of cardiac resynchronization therapy on left ventricular function, myocardial energetics, and metabolic reserve in patients with dilated cardiomyopathy and heart failure.
    Sundell J; Engblom E; Koistinen J; Ylitalo A; Naum A; Stolen KQ; Kalliokoski R; Nekolla SG; Airaksinen KE; Bax JJ; Knuuti J
    J Am Coll Cardiol; 2004 Mar; 43(6):1027-33. PubMed ID: 15028362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical studies concerning etiology of hypertrophy, heart failure, and cardiomyopathy.
    Schwartz A
    Recent Adv Stud Cardiac Struct Metab; 1973; 2():501-2. PubMed ID: 4283354
    [No Abstract]   [Full Text] [Related]  

  • 8. [Heart failure in dilated cardiomyopathy. A disorder of cellular calcium homeostasis].
    Beuckelmann DJ; Erdmann E
    Dtsch Med Wochenschr; 1991 Mar; 116(13):504-8. PubMed ID: 2007382
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of growth hormone in chronic heart failure: therapeutic implications.
    Volterrani M; Giustina A; Manelli F; Cicoira MA; Lorusso R; Giordano A
    Ital Heart J; 2000 Nov; 1(11):732-8. PubMed ID: 11110515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Function and role of the sarcoplasmic reticulum in heart disease].
    Reyes-Juárez JL; Zarain-Herzberg A
    Arch Cardiol Mex; 2006; 76 Suppl 4():S18-32. PubMed ID: 17469332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Myocardium-induced heart failure. Disorder of electromechanical conduction].
    Beuckelmann DJ
    Fortschr Med; 1992 Mar; 110(8):134. PubMed ID: 1582641
    [No Abstract]   [Full Text] [Related]  

  • 12. Abnormal intracellular calcium handling, a major cause of systolic and diastolic dysfunction in ventricular myocardium from patients with heart failure.
    Morgan JP; Erny RE; Allen PD; Grossman W; Gwathmey JK
    Circulation; 1990 Feb; 81(2 Suppl):III21-32. PubMed ID: 2153479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Administration of insulin-like growth factor-1 (IGF-1) improves both structure and function of delta-sarcoglycan deficient cardiac muscle in the hamster.
    Serose A; Prudhon B; Salmon A; Doyennette MA; Fiszman MY; Fromes Y
    Basic Res Cardiol; 2005 Mar; 100(2):161-70. PubMed ID: 15611844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental cardiac hypertrophy and heart failure. Erwin Riesch Symposium, Tübingen, April 5-7, 1979.
    Basic Res Cardiol; 1980; 75(1):1-293. PubMed ID: 6446281
    [No Abstract]   [Full Text] [Related]  

  • 15. Remarks on the biochemical and physical basis of congestive cardiac failure in cardiomyopathy.
    Brink AJ
    Recent Adv Stud Cardiac Struct Metab; 1973; 2():1-5. PubMed ID: 4806965
    [No Abstract]   [Full Text] [Related]  

  • 16. [Myocardial metabolism of calcium in heart failure: from physiology to new therapeutic perspectives].
    Casaburi C; Di Rella F; Riccio G; Angelillo N; Ettari G; Troise A; De Simone G; Longobardi S; Fazio S; Morgan JP; Cittadini A
    Ital Heart J Suppl; 2000 Jun; 1(6):766-71. PubMed ID: 11204008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of post-exercise blood pressure response in patients with dilated cardiomyopathy.
    Kitaoka H; Hitomi N; Okawa M; Furuno T; Doi Y
    J Cardiol; 2003 Oct; 42(4):165-71. PubMed ID: 14598718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial performance and efficiency as assessed by energetic parameters derived from pressure-volume relations and wall thickness in human ventricles.
    Holubarsch C; Hasenfuss G; Körner M; von Herrath M; Bonzel T; Tarnowska R; Just H
    Z Kardiol; 1986; 75 Suppl 2():100-4. PubMed ID: 3727668
    [No Abstract]   [Full Text] [Related]  

  • 19. Cardiomyopathy of overload. A major determinant of prognosis in congestive heart failure.
    Katz AM
    N Engl J Med; 1990 Jan; 322(2):100-10. PubMed ID: 2403651
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cardiac insufficiency. Definition, mechanisms, principles of treatment].
    Himbert D; Jaeger P; Steg PG; Makowski S; Gourgon R
    Arch Mal Coeur Vaiss; 1990 Nov; 83(13):1913-8. PubMed ID: 2148669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.